RecruitingNot applicableNCT06027255

Long COVID Immune Profiling

Studying Rare autonomic nervous system disorder

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Vanderbilt University Medical Center
Intervention: IL-6(diagnostic_test)
Enrollment: 150 target
Eligibility: 18 years · All sexes
Timeline: 2024 – 2027

Study locations (1)

Cyndya Shibao, Nashville, Tennessee, United States

Collaborators

American Heart Association

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06027255 on ClinicalTrials.gov

Other trials for Rare autonomic nervous system disorder

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE2NCT07089043
A Study in Subjects With Neurogenic Orthostatic Hypotension
CuraSen Therapeutics, Inc.
RECRUITINGNANCT06841198
Cardiovascular Function and Response to Stimulation Within the First Year After Spinal Cord Injury
Kessler Foundation
RECRUITINGNANCT06694688
Evaluation of the Contribution of Lower Limb and/or Abdominal Compression on Orthostatic Hypotension
Gérond'if
RECRUITINGNANCT07195903
The STAND-UP Study
St. Francis Hospital, New York
RECRUITINGNANCT06587841
Noninvasive Spinal Cord Stimulation for Early SCI
University of British Columbia
RECRUITINGPHASE2NCT06188663
SalT Supplementation in Older Adults With Orthostatic Intolerance Disorders
University of Galway
RECRUITINGNANCT05908760
CO2 Rebreathing in nOH: A Proof-of-Concept Pilot Study
University of Calgary
ACTIVE NOT RECRUITINGNCT06439498
Frequency of Orthostatic Hypotension in Patients Who Underwent Colonoscopy
Ankara University

See all trials for Rare autonomic nervous system disorder →

← Back to all trials